About Clinical Insights Research Group
Clinical Insights Research Group is the research division of Capital Gastro. our commitment to cutting-edge care extends into our dedicated research division, Clinical Research Insights Group has conducted clinical trials . Since 2017, we have actively participated in clinical trials, contributing essential data to the advancement of gastroenterology.
A History of Impact
Led by our Principal Investigator, Dr. Masi Khaja, who has overseen over 15 studies, our research has focused on testing and developing new medications for complex conditions, including: Crohn’s Disease, Ulcerative Colitis, Colorectal and Cervical Cancer, Liver Fibrosis, and NASH (Non-Alcoholic Steatohepatitis).
The Opportunity for Our Patients
Our clinical studies, conducted by the Clinical Insights Research Group, offer a path for patients seeking an alternative when standard GI treatment methodologies are not working. If you have not seen improvement or have experienced side effects from your current regimen, a clinical trial may be an option for you. We give preference to interested participants who want to play an active role in shaping the future of gastrointestinal medicine.